vimarsana.com
Home
Live Updates
Imetelstat Shows Potential to Transform QOL in Lower-Risk MDS : vimarsana.com
Imetelstat Shows Potential to Transform QOL in Lower-Risk MDS : vimarsana.com
Imetelstat Shows Potential to Transform QOL in Lower-Risk MDS
Sunil Iyer, MD, expands on the potential role of imetelstat for select patients with lower-risk myelodysplastic syndrome.
Related Keywords
New York ,
United States ,
Sunil Iyer ,
Oncologic Drugs Advisory Committee ,
Meeting Of The Oncologic Drugs Advisory Committee ,
Columbia University Irving Medical Center ,
International Prognostic Scoring System ,
Drugs Advisory Committee ,
Science Summit ,
New York City ,
D ,
Mds ,
Lower Risk Myelodysplastic Syndrome ,
Imetelstat ,
Phase 2 3 Imerge Mds3001 Trial Nct02598661 ,